Table 1: Departmental Planned Spending and Full Time Equivalents
| ($ millions) |
Forecast Spending 2005-2006 |
Planned Spending 2006-2007 |
Planned Spending 2007-2008 |
Planned Spending 2008-2009 |
| Health Policy. Planning and Information |
448.4 |
288.6 |
218.2 |
214.9 |
| Health Products and Food |
262.4 |
303.2 |
298.4 |
283.1 |
| Healthy Environments and Consumer Safety |
287.8 |
306.1 |
301.7 |
301.3 |
| Pest Control Product Regulation |
58.3 |
58.7 |
58.2 |
54.1 |
| First Nations and Inuit Health |
1.867.7 |
2.087.9 |
2.126.9 |
2.138.8 |
| Budgetary Main Estimates (gross) |
2.924.6 |
3.044.5 |
3.003.4 |
2.992.2 |
| Less: Respendable Revenues |
68.9 |
69.1 |
69.4 |
69.7 |
| Total Main Estimates |
2.855.7 |
2.975.4 |
2.934.0 |
2.922.5 |
|
Adjustments: 1
Governor General Special Warrants:
|
| Operating Budget Carry Forward (horizontal item) |
14.1 |
|
|
|
| Additional funding in support of Aboriginal health further to the Special Meeting of First Ministers and Aboriginal
Leaders on September 13. 2004 |
25.5 |
|
|
|
| Additional funding to territories for medical travel costs and health systems reform (TB vote 5) |
30.0 |
|
|
|
| Additional funding for initiatives related to the 10-Year Plan to Strengthen Health Care. such as wait times reduction.
internationally educated health care professionals. and improved reporting to Canadians on the progress made in
strengthening health care ($15.0 million from TB Vote 5) |
25.7 |
|
|
|
| Funding to ensure the safety of therapeutic products. including enhanced clinical trials oversight. monitoring of drugs
and medical devices in the marketplace. and the implementation of new regulations for blood transfusion and organ
transplantation (horizontal item) |
2.6 |
|
|
|
| Funding to enhance early learning and childcare programs for First Nations on reserve (horizontal item) |
6.1 |
|
|
|
| Additional funding for health risk assessments and protection measures related to the Canadian Environmental
Protection Act |
1.7 |
|
|
|
| Activities to mitigate the impact of the Bovine Spongiform Encephalopathy (BSE) crisis (horizontal item) |
1.1 |
|
|
|
| Funding to deliver federal programs and services. including health in two Labrador Innu communities (Labrador Innu
Comprehensive Healing Strategy) (horizontal item) |
3.9 |
|
|
|
| Funding to continue the Government's plan to establish core genomics research and development capacity (horizontal item) |
0.2 |
|
|
|
| Additional funding for the Access to Medicines Program which provides affordable access to Canadian patented
pharmaceuticals for the treatment of HIV/AIDS. malaria. tuberculosis and other epidemics. in the least developed and
developing countries |
0.7 |
|
|
|
| Funding related to the assessment. management and remediation of federal contaminated sites (horizontal item) |
0.6 |
|
|
|
| Funding to strengthen initiatives in support of the Canadian Strategy on HIV/AIDS in Canada (horizontal item) ($0.8
million from TB Vote 5) |
1.2 |
|
|
|
| Funding to improve the capacity to detect and the readiness to respond to a potential pandemic influenza outbreak
including emergency preparedness. antiviral stockpiling and rapid vaccine development technology (horizontal item) |
0.4 |
|
|
|
| Funding for the environmental clean-up of the Sydney Tar Ponds and Coke Oven Sites in the Muggah Creek Watershed
(horizontal item) |
0.1 |
|
|
|
| Funding to launch an integrated public health strategy to reduce the impact of chronic disease by promoting healthy living
including specific initiatives to combat diabetes. cancer and cardiovascular disease (horizontal item) |
0.2 |
|
|
|
| Funding to undertake projects related to the development and application of biotechnology (Canadian Biotechnology
Strategy) (horizontal item) |
0.2 |
|
|
|
| Funding for the development of and reporting on environmental indicators related to clean air. clean water and greenhouse
gas emissions (horizontal item) |
0.2 |
|
|
|
| Funding for the delivery of federal programs and services. including health. to the O-Pipon-Na-Piwin Cree Nation
(horizontal item) |
0.1 |
1.5 |
1.6 |
0.4 |
| Less: Spending authorities available |
-61.0 |
|
|
|
| Other adjustments: |
| Collective Agreements |
41.4 |
|
|
|
| Joint Career Transition Committee (TB Vote 10) |
0.1 |
|
|
|
| Adjustment - Statutory Items |
0.4 |
|
|
|
| EBP Adjustment |
7.9 |
|
|
|
| Funding for the Genomics Research and Development Initiative. under the auspices of the Canadian Biotechnology Strategy |
|
|
|
4.0 |
| Funding to Recognize a Landless Band and for the Registration of Newfoundland Indians |
|
7.3 |
7.5 |
7.8 |
| Funding for the Winter Olympics |
|
|
|
0.6 |
| One year extension of funding authority for First Nations and Inuit Non-Insured Health Benefits Program Review |
|
30.0 |
|
|
| Funding for the Settlement Agreement for Indian Residential Schools |
|
|
2.0 |
11.0 |
| Funding for Avian and Pandemic Influenza Preparedness. with a Focus on Animal and Human Health |
|
1.5 |
4.0 |
4.0 |
| Government Wide Efficiencies - Procurement Savings |
|
-4.6 |
|
|
| Year End Lapse 2 |
-66.9 |
|
|
|
| Total Adjustments |
36.3 |
35.7 |
15.1 |
27.8 |
| Total Planned Spending 3 |
2,892.0 |
3,011.1 |
2,949.1 |
2,950.3 |
| Less: Non-respendable Revenue |
8.9 |
8.9 |
8.9 |
8.9 |
| Plus: Cost of services received without charge 4 |
85.6 |
84.7 |
84.6 |
84.6 |
| Total Departmental Spending |
2,968.7 |
3,086.9 |
3,024.8 |
3,026.0 |
| Full-Time Equivalents 5 |
8,544.0 |
8,711.0 |
8,773.0 |
8,671.0 |
|
1 Adjustments reflect Governor General Special Warrants and TB Vote 5 Access for
2005-2006.
2 Year-end Lapse as per the 2005-2006 Public Accounts.
3 Refer to Section 2 for an explanation by program activity of year-over-year fluctuations.
4 Includes the following services received without charge: accommodation charges (Public
Works and Government Services Canada); contributions covering employers' share of employees' insurance premiums and
expenditures (Treasury Board Secretariat); Workers' Compensation (Human Resources and Skills Development Canada); and Legal
Services
(Department of Justice Canada).
5 Full-time equivalents reflect the human resources that the Department uses to deliver its
programs and services. This number is based on a calculation that considers full-time. term. casual employment. and other
factors such as job sharing.
|
Table 7: Major Regulatory Initiatives
| Part A - New Initiatives |
| Program Activity: Health Policy, Planning And Information |
| Regulations |
Expected Results |
| Regulations under the Assisted Human Reproduction Act |
New regulations will protect the health and safety of Canadians who use assisted human reproduction (AHR) procedures and
ensure that AHR-related research, which may help find treatments for infertility and diseases, takes place in a controlled
environment. Regulated activities include embryo research, clinical and laboratory practices and pre-implantation genetic
diagnosis. The regulatory framework will also include a licensing framework for AHR activities, and provisions governing the
reimbursement of expenditures, counselling, and the reporting of health information. |
| Program Activity: Health Products And Food |
| Regulations |
Expected Results |
| Food and Drug Regulations (Amendments to Division 3 respecting Positron Emitting Radiopharmaceuticals) |
Amendment to Part C, Division 3 of the Food and Drug Regulations to provide for an exemption for the requirement
to file Clinical Trial applications for certain radiopharmaceutical studies. The amended regulations will eliminate
regulatory burden for certain limited basic research studies, while helping to ensure that patient safety is not
compromised. |
| Food and Drug Regulations (Introduction of Emergency Use New Drug Regulations in Division 8) |
Division 8 of the Food and Drug Regulations requires manufacturers of new drugs intended for sale in Canada to
provide substantial evidence of clinical effectiveness in humans. This initiative will provide Health Canada with a formal
mechanism to approve products which only contain substantial evidence of clinical effectiveness in animal or in-vitro
studies for use in emergency situations and meet emergency preparedness measures, such as the approval and distribution of a
vaccine for the treatment and prevention of a pandemic influenza virus. |
| Food and Drug Regulations (Prohibition of Importation for Personal Use) |
Increase the scope of the prohibition on importation of veterinary drugs to include the personal importation of drugs
intended to be used in food-producing animals to avoid potentially harmful residues in food products from animals treated
with these drugs. |
| Food and Drug Regulations (Carbadox) |
Prohibition of sale of products containing carbadox for sale in Canada to avoid potentially harmful residues in food
products from animals treated with this drug. |
| Medical Device Regulations (Introduce additional requirements for investigational testing for medical devices) |
Further address risks to health associated with investigational testing by requiring conformity to Good Clinical
Practices, reporting to Health Canada for reviewing/ monitoring, and introducing an inspection program. |
| Medical Device Regulations (Amendment to regulate the reprocessing of single-use devices) |
The amended regulations will mitigate the risks associated with the reprocessing of single-use devices by requiring
reprocessors of single-use devices to operate under a standards-based licencing program administered by Health Canada. |
| Food and Drug Regulations (Regulations amending Divisions 1 and 8, Progressive Licensing Project) |
A new regulatory framework that is based on sound science and risk management is being developed, including revised
requirements for initial licensing of new products, provisions allowing for conditions of licensing (e.g., post-market
commitments), regulations for the content and revisions of product monographs, provisions for continual evaluation and
re-evaluation of licenses, new enforcement and compliance tools, regulations for the issuance of risk communication tools,
and provisions for public involvement in the regulatory process. |
| Program Activity: Pest Control Product Regulation |
| Regulations |
Expected Results |
| Pest Control Products Act (Sales Information Reporting Regulations) |
New regulations will specify how pest control product sales information will be collected by specifying the requirements
for recording, retaining and reporting sales of pest control products. |
| Part B - Ongoing Initiatives |
| Program Activity: Health Products And Food |
| Regulations |
Expected Results |
| Food and Drugs Act (New regulatory framework for cells, tissues and organs intended for use in transplantation) |
The new regulations will aim to balance the need for safe cells, tissues, and organs of high quality with the need to
ensure the availability of cells, tissues and organs for transplantation. Phase I regulations will focus on the basic safety
requirements for human cells, tissues and organs. Phase II regulations will include adverse event reporting requirements and
a compliance and enforcement strategy. |
| Food and Drugs Act (New Regulations Respecting Blood and Blood Components) |
The new regulations will aim to balance the need for safe blood and blood components with the need to ensure their
availability for transfusion. They will include basic safety requirements, adverse event reporting requirements and a
compliance and enforcement strategy. |
| Food and Drug Regulations (Amendment to provisions respecting plasmapheresis in Division 4 of Part C) |
The amended regulations will reflect current methods and practices used to collect human plasma as well as the list of
transmissible diseases for which tests must be performed in order to maximize the safety of plasma and plasma donors. |
| Food and Drugs Act (Amendment to the Processing and Distribution of Semen for Assisted Conception Regulations) |
The amended regulations will reflect current safety standards for semen used in assisted conception. |
| Food and Drug Regulations (Addition of Vitamins and Minerals to Foods) |
Facilitation of greater consumer choice and industry innovation by revision of regulations on the addition of vitamins and
mineral nutrients to foods taking into account the role of nutrient addition to foods, consumer needs and expectations, and
industry requests. |
| Food and Drug Regulations (Enhanced Labelling) |
Enhanced protection of allergic consumers through mandatory labelling of specific food allergens, gluten sources and
sulphites when present at 10 parts per million or more on the labels of prepackaged food products, whether they have been
added directly or indirectly. |
| Food and Drug Regulations (Mandatory Labelling of Raw Ground Meat and Ground Poultry) |
Reduction of foodborne illness as a result of providing safe handling information on the labels of these products which,
due to their raw state, can introduce diseasecausing bacteria to the food preparation environment. |
| Food and Drug Regulations (Health Claims) |
Addition of two diet-related health claims to the list of claims manufacturers can use to promote healthy foods (e.g.,
fruits, vegetables and whole grains and reduced risk of heart disease, folic acid and reduced risk of neural tube defects). |
| Food and Drug Regulations (Saccharin) |
Availability of an additional intense sweetener to allow a wider range of low sugar or sugar free food products for the
benefit of consumers who wish to consume these products. |
| Food and Drug Regulations (Caffeine) |
Additional label information on levels of caffeine in prepackaged beverages, including caffeine containing energy drinks,
to allow consumers to make an informed choice about their caffeine intake. |
| Food and Drug Regulations (Labelling of Unpasteurized Juice) |
Reduction of foodborne illness related to the consumption of prepackaged unpasteurized juice products by providing
additional information on the labels of these products. |
| Food and Drug Regulations (Revisions to Division 12 - Prepackaged Water and Ice) |
Modernization and expansion of the safety and labelling requirements for prepackaged water and ice products. |
| Food and Drug Regulations (Regulations amending the Special Access Program) |
The current Special Access Program allows for the use of unauthorized drugs prescribed to patients on an individual basis.
The amendment will allow for the block release of unauthorized drugs to a population and/or for stockpiling to address
public health emergencies. |
| Food and Drug Regulations (Regulations amending the data protection provisions) |
The data protection provisions are being amended to provide effective data protection for a period of eight years for
innovator drugs that contain medicinal ingredients not previously approved for sale in Canada. Submissions including
pediatric studies that were designed and conducted with the purpose of increasing knowledge about the drug in pediatric age
groups will be protected for an additional six months. |
| Program Activity: Healthy Environments And Consumer Safety |
| Regulations |
Expected Results |
| Controlled Drugs and Substances Act (Regulations to expand the authority for regulated health professionals to
prescribe controlled substances where appropriate) |
Federal legislation will not unnecessarily restrict the professional practice of any health profession regulated by
provincial or territorial (P/T) authorities, including practitioners of medicine, dentistry, veterinary medicine, podiatric
medicine, midwifery, and nurse practitioners, with respect to the use of controlled substances in the treatment of their
patients. This result will be achieved over the next 2 to 3 years as federal and P/T regulations are amended to allow health
professionals to prescribe controlled substances in accordance with the standards of professional practice defined by their
regulatory authorities. Achievement will be measured by improved alignment of federal and P/T regulatory frameworks
governing the appropriate use of controlled substances for medical purposes. |
| Tobacco Advertising Regulations |
Increased awareness of tobacco-related health hazards through mandating of new health warnings in advertising. Awareness
will be measured through surveys. |
| Tobacco Act (Amendment to the Tobacco Labelling Regulations) |
Increased awareness of tobacco-related hazards through the introduction of new health warnings on packaging. Awareness
will be measured though surveys. |
| Tobacco Regulations (Amendments regarding "Light" and "Mild" Descriptors) |
Reduced confusion among smokers regarding these descriptors. Greater awareness that no class of cigarettes is a
"safer" alternative. Achievements will be measured through surveys. |
| Tobacco Retail Promotion Regulations |
Reduced visibility of tobacco promotion at retail. Achievements will be measured through surveys at retail |
| Program Activity: Pest Control Product Regulation |
| Regulations |
Expected Results |
| Pest Control Products Regulations |
Revised regulations will include changes to clarify and modernize the Pest Control Product Regulations (PCPR) to
make the PCPR coherent with the new Pest Control Products Act, and to formalize current procedures and practices
for better compliance. |
| Pest Control Products Act (Amendments to the Agriculture and Agri-Food Administrative Monetary Penalties
Regulations) |
Revised regulations will address violations under the new Pest Control Products Act and regulations. |
| Pest Control Products Act (New regulations on review panels) |
The new Pest Control Product Act includes a process for the reconsideration of major registration decisions by a
review panel. New regulations will specify the parameters for establishing review panels and for the selection and
remuneration of panel members. This will contribute to better public participation in the regulatory process, increased
transparency and increased public and stakeholder confidence in pesticide regulation. |
| Pest Control Products Act (New regulations on the reporting of adverse effects from the use of pest control
products) |
New regulations will specify the prescribed information and time frames for reporting adverse effects of pest control
products. This will contribute to strengthened health and environmental protection. |
Table 11: Sustainable Development Strategy
|
Health Canada's current Sustainable Development Strategy entitled Becoming the Change We Wish to See is a three year
strategic plan that tells Canadians and Parliament what general and specific commitments Health Canada has made to
sustainable development (SD). To build on the success of the previous strategy, the Department's third strategy continues
with the themes identified in the previous one. These key themes are:
- Helping to create healthy social and physical environments.
- Integrating sustainable development into departmental decision-making and management processes.
- Minimizing the environmental and health effects of the Department's physical operations and activities.
Whereas the Department's first strategy contained over 100 commitments, this Strategy focuses on 20 commitments,
highlights how employees are an integral part of the overall plan, and identifies a number of practical tools to help
incorporate sustainable development at work and at home.
|
| Sustainable Development Strategy Commitments |
1.1.1:
In partnership with federal, provincial and territorial departments of health and environment, Health Canada will develop an
integrated, source-to-tap approach to drinking water quality in Canada. |
1.1.2:
Health Canada will work with other federal departments to develop a compliance framework for drinking water quality in areas
of federal jurisdiction. |
1.1.3:
Health Canada, in conjunction with other federal departments, will reduce cross-border air pollution by undertaking pilot
projects that enable greater opportunities for coordinated air quality management between Canada and the United States. |
1.1.4
Health Canada will collaborate with partners and other federal departments to assess climate change impacts on human health
and well-being, and research and develop approaches to adaptation planning and implementation as part of the Climate Change
Plan for Canada. |
1.1.5:
Health Canada will work in consultation with stakeholders to develop and/or update science-based guidelines and standards to
improve the safety of the food supply and reduce foodborne illness. |
1.1.6:
Health Canada will help prevent the exploitation of flora and fauna used for medicinal purpose |
1.1.7:
Health Canada will improve its process for making regulatory decisions for pest control products, including providing access
to safer products, and will provide information on pest control products and on sustainable pest management practices. |
1.2.1:
Health Canada will work in collaboration with First Nations and Inuit and provinces and territories to better integrate
health services for a sustainable, seamless system of health services for First Nations and Inuit. |
2.1.1:
Health Canada will improve the integration of SD considerations within the Department by developing a framework to identify
key planning, reporting activities and modern management practices that could incorporate SD considerations, and will
integrate sustainable development into these areas where appropriate by March 31, 2007. |
2.1.2:
Health Canada will improve the integration of SD considerations within the Department by effectively integrating SD into key
departmental policies, legislation and contracts where appropriate, and establishing a formal process to evaluate this
integration by March 31, 2007. |
2.1.3:
Health Canada will increase employee awareness about sustainable development by developing and implementing a social
marketing campaign for March 31, 2007. |
2.1.4:
Health Canada will increase employee awareness about sustainable development by developing and implementing a departmental
training curriculum on sustainable development to be provided to at least 1,000 Health Canada employees by March 31, 2007. |
2.1.5:
Health Canada will contribute to increase federal employee awareness of sustainable development through partnering with
other government departments, federal committees and networks to design and deliver an interdepartmental course about
sustainable development by March 31, 2007. |
3.1.2:
By March 2007, Health Canada commits to providing facility managers and other managers with authorities over facilities with
training on the sustainable operation and management of Health Canada facilities. The training will be based on the
departmental guidebook. |
3.2.3:
By January 2007, Health Canada will begin implementing and reporting the recommendations outlined in the departmental
pollution prevention guidebook and action plan. |
|
Since the first strategy, Health Canada has worked to create a culture that recognizes the importance of sustainable
development in its operations. Approval of a Sustainable Development Policy in December 2000 enabled the integration of five
key principles (shared responsibility, integrated approaches, equity, accountability, and continuous improvement) into the
Department's third Sustainable Development Strategy. They will act as guiding principles for the development of the next
strategy covering 2007 to 2010, to be tabled in Parliament in December 2006. The Department will continue to report annually
on progress made on SD Strategy commitments.
Strategic Environmental Assessment (SEA) is a systematic and comprehensive process for evaluating the environmental
effects of a policy, plan or program and its alternatives, at the earliest stage in planning. Health Canada has a
requirement to complete SEAs in conformance with the 2004 Cabinet Directive on the Environmental Assessment of Policy,
Plan and Program Proposals. Health Canada has developed a policy and guidelines for strategic environmental assessment
to support departmental efforts to ensure proposals with important positive or negative environmental effects are identified
and enhancement or mitigation measures are identified. The Department is committed to providing training on this initiative
to policy staff as required and will continue to consider the environmental impacts of our activities.
Additionally, use of an environmental management system, or EMS, is another way to promote sustainable development. Two
of the priorities of the EMS Division are the review of the EMS to reflect the multiple changes within the federal
government and the revamping of the EMS database (the primary resource for environmental information). Some preliminary work
on the EMS database has already started and will continue in 2006-2007. Other databases in the Health Portfolio used to
capture environmental information include a fleet database for tracking vehicle operations and a hazardous waste database
for some hazardous streams.
Building on previous experiences and incorporating best practices in our work will help to achieve sustainable
development in the long term.
|
Table 12: Internal Audits and Evaluations
| Project Title |
Estimated Completion Date1 |
| Recently Completed Internal Audits |
| Review of the Administration of the Health Canada Contract with First Canadian Health Management Corporation Inc. |
Approved by the DA&EC on April 7, 2005 |
| Follow-up of the Directed Audit of Société Santé en Français Inc. |
Approved by the DA&EC on November 1, 2005 |
| Upcoming Internal Audits |
| Audit of the Handling of Controlled Drug Substances (CDS) in FNIHB Health Facilities within Two Selected Regions |
Approved by the DA&EC April 2006 |
| Audit of Primary Health Care Transition Fund (PHCTF) Contributions to the Ministry of Health and Long Term Care of the
Province of Ontario |
Fall 2006 |
| Audit of Selected Administrative Areas |
Summer 2006 |
| Audit of Health Canada Initiatives for GOL |
Approved by the DA&EC June 2006 |
| Audit of IT Security in Health Canada |
Fall 2006 |
| Audit of the Implementation of Corrective Measures Ordered by the Public Service Commission |
Fall 2006 |
| Selected Results-Based Management Accountability Frameworks |
January 2007 |
| Audit of Mental Health and Addictions Programs |
January 2007 |
| Audit of the Drug Strategy and Controlled Substances Programme |
January 2007 |
| Recently Completed Evaluations |
| Evaluation of the Memorandum of Understanding between the Assistant Deputy Ministers and Regional Directors General |
Approved by the DA&EC November 2005 |
| Evaluation of the Health Canada Innovation Fund |
Approved by the DA&EC November 2005 |
| Evaluation of the Canada Health Infostructure Partnership Program |
Approved by the DA&EC November 2005 |
| Impact Evaluation of the Health Transition Fund |
Approved by the DA&EC November 2005 |
| Formative Review of the Research Management and Dissemination Division |
Approved by the DA&EC November 2005 |
| Health Transfer Policy - FNIHB |
Approved by the DA&EC April 2006 |
| Brighter Futures and Building Healthy Communities Program - FNIHB |
Approved by the DA&EC April 2006 |
| Non-Insured Health Benefits Pilot Projects - FNIHB |
Approved by the DA&EC April 2006 |
| Primary Health Care Transition Fund - interim evaluation - Health Policy Branch (HPB) |
Approved by the DA&EC April 2006 |
| Cost Recovery in the Pest Management Regulatory Agency |
Approved by the DA&EC April 2006 |
| Health Care Strategies and Policy Grant and Contribution programs - Performance Measurement System Review - HPB |
Approved by the DA&EC June 2006 |
| Upcoming Evaluations |
| Review of Evaluation and Performance Measurement at Health Canada - CFOB |
Fall 2006 |
| First Nations and Inuit Home and Community Care Program - FNIHB |
Fall 2006 |
| Canada Prenatal Nutrition Program - FNIHB |
Fall 2006 |
| Aboriginal Diabetes Initiative - FNIHB |
Winter 2006-2007 |
| Augmenting Health Canada's Response to Bovine Spongiform Encephalopathy (BSE) - BSE I phase II of Health Canada's and the
PHAC's response to BSE in the areas of Risk Assessment and Targeted Research - BSE II |
Fall 2006 |
| Federal Drinking Water Compliance Program (HECS) |
Winter 2006-2007 |
| Federal Tobacco Control Strategy |
March 2007 |
| Contribution Program for Improving Access to Health Services for Official Languages Minority Communities - HPB |
Winter 2006-2007 |
| Canadian Regulatory System for Biotechnology - HPFB |
Fall 2006 |
| Therapeutics Access Strategy - HPFB |
Fall 2006 |
| Natural Health Products Research Program - HPFB |
Fall 2006 |
| Drug Strategy and Controlled Substances Program, Canada's Drug Strategy Renewed Year 2 - HECSB |
Fall 2006 |
| Canadian Environmental Protection Act - HECSB |
Fall 2006 |
| Building Public Confidence in Pesticide Regulation and Improving Access to Pest Management Products - PMRA |
Fall 2006 |
| Expenditure Review Reductions and the Impact on Health Canada - DAEC/DPMED |
Winter 2006-2007 |
| Contracting for Professional and Special Services in Health Canada - DAEC/DPMED |
Winter 2006-2007 |
| 1 The 'Estimated Completion Date' is the date the internal audit or
evaluation report is expected to be tabled for approval by Health Canada's Departmental Audit and Evaluation Committee
(DA&EC). |
This page has been archived.